In Peer Reviewed Journals
Altman DG. Poor-quality medical research: what can journals
do? JAMA 2002; 287: 2765-2767.
Altman DG, Deeks JJ. Meta-analysis, Simpson’s
paradox, and the number needed to treat. BMC Med Res Methodol 2002; 2: 3.
Altman DG, Goodman SN, Schroter S. How statistical expertise
is used in medical research. JAMA 2002; 287: 2817-2820.
Altman DG, Schulz KF, Moher D, Egger M, Davidoff, Elbourne
D, Gøtzsche PC, Lang T for the CONSORT Group. The revised CONSORT statement for
reporting randomized trials: explanation and elaboration. Clin Eval
2002; 30: 163-208. (In Japanese) [translation of Altman et al. Ann
Intern Med 2001; 134: 663-694.]
Borley
NR, Mortensen NJM, Chaudry MA,
Mohammed S, Clark T, Jewell DP. Evidence for separate disease phenotypes in
intestinal Crohn’s disease. Br J Surg 2002; 89: 201-205.
Borley
NR, Mortensen NJM, Chaudry MA,
Mohammed S, Warren BF, George BD, Clark T, Jewell DP, Kettlewell MGW.
Recurrence after abdominal surgery for Crohn’s disease: relationship to disease
site and surgical procedure. Dis Colon Rectum 2002; 45: 377-383.
Chitty
LS, Altman DG. Charts of fetal size: limb bones. Br J Obstet Gynaecol
2002; 109: 919-929.
Clark TG,
Altman DG, De Stavola BL. Quantifying the completeness of follow-up. Lancet
2002; 359: 1309-1310.
Curtin F,
Altman DG, Elbourne D. Meta-analysis combining parallel and cross-over
clinical trials. I: Continuous outcomes. Stat Med 2002; 21: 2131-2144.
Curtin F,
Elbourne D, Altman DG. Meta-analysis combining parallel and cross-over
clinical trials. II: Binary outcomes. Stat Med 2002; 21: 2145-2159.
Curtin F,
Elbourne D, Altman DG. Meta-analysis combining parallel and cross-over
clinical trials. III: The issue of carry-over. Stat Med 2002; 21: 2161-2173.
Dalley
CD, Lillington DL, Bradburn M, Carter M, Amess JA, Rohatiner AZS, Lister
TA. Acute myelogenous leukaemia in older patients at St Bartholomew’s Hospital:
outcome with mitoxantrone and cytarabine. Hematol J 2002; 3: 237-243.
Dawson J,
Thorogood M, Marks SA, Juszczak E, Dodd C, Lavis G, Fitzpatrick R. The
prevalence of foot problems in older women: a cause for concern. J Public
Health Med 2002; 24: 77-84.
Deeks JJ. Issues in the selection of a summary statistic in
meta-analysis of clinical trials with binary outcomes. Stat Med 2002;
21: 1575-1600.
Deeks JJ,
Smith LA, Bradley MD. Celecoxib versus
NSAIDs for management of osteoarthritis and rheumatoid arthritis: evidence of
efficacy, tolerability and upper gastrointestinal safety from a systematic
review of randomised controlled trials. BMJ 2002; 325: 619-663.
Elbourne
DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A.
Meta-analyses involving cross-over trials. Int J Epidemiol 2002; 31:
140-149.
Festing
MFW, Altman DG. Guidelines for the design and statistical analysis of
experiments using laboratory animals. ILAR J 2002; 43: 244-258.
Graham J,
Ramirez A, Love S, Richards M, Burgess C. Stressful life experiences and
risk of relapse of breast cancer: observational cohort study. BMJ 2002; 324: 1420-1422.
Hawton K,
Rodham K, Evans E, Weatherall R. Deliberate self harm in adolescents:
self report survey in schools in England. BMJ 2002; 325: 1207-1211.
Hawton K,
Simkin S, Rue J, Haw C, Barbour F, Clements A, Sakarovitch C, Deeks J.
Suicide in female nurses in England and Wales. Psychol Med 2002; 32:
239-250.
Higgins
J, Thompson S, Deeks J, Altman D. Statistical heterogeneity in
systematic reviews of clinical trials: a critical appraisal of guidelines and
practice. J Health Serv Res Policy 2002; 7: 51-61.
James
ACD, Javaloyes A, James S, Smith DM. Evidence for non-progressive changes in
adolescent-onset schizophrenia: follow up magnetic resonance imaging study. Br
J Psychiatry 2002; 180: 339-344.
Jenkinson
C, Mayou R, Day A, Garratt A, Juszczak E. Evaluation of the Dartmouth
COOP charts in a large-scale community survey in the United Kingdom. J
Public Health Med 2002; 24: 106-111.
Johnstone
E, Clark TG, Griffiths SE, Murphy MFG, Walton RT. Polymorphisms in dopamine
metabolic enzymes and tobacco consumption in smokers: seeking confirmation of
the association in a follow-up study. Pharmacogenetics 2002, 12:
585-587.
Liu JLY, Maniadakis N, Gray A, Rayner M. The economic
burden of coronary heart disease in the United Kingdom. Heart 2002; 88: 597-603.
The
Magpie Trial Collaborative Group [includes Altman D, Smith D]. Do women
with pre-eclampsia, and their babies, benefit from magnesium sulphate? The
Magpie Trial: a randomised placebo controlled trial. Lancet 2002; 359:
1877-1890.
McDonald
FE, Ironside JW, Gregor A, Wyatt B, Stewart M, Rye R, Adams J, Potts HWW. The prognostic influence of
bcl-2 in malignant glioma. Br J Cancer 2002; 86: 1899-1904.
McManus
RJ, Mant J, Davies MK, Davis RC, Deeks JJ, Oakes RA, Hobbs FDR. A
systematic review of the evidence for rapid access chest pain clinics. Int J
Clin Pract 2002; 56: 29-33.
Moher D,
Schulz KF, Altman D. The CONSORT statement: Revised recommendations for
improving the quality of reports of parallel-group randomized trials.
Altern
Ther Health Med 2002; 8:
96-100. 2002; 6: 118-124. (in Japanese)
JAMA
[Japanese edition]
Müllner
M, Matthews H, Altman DG. Reporting on statistical methods to adjust for
confounding: a cross-sectional survey. Ann Intern Med 2002; 136: 122-126.
O’Rourke
K. Meta-analytical themes in the
history of statistics: 1700 to 1938. Pakistan J Stat 2002; 18: 285-299.
Passalidou
E, Trivella M, Singh N, Ferguson M, Hu J, Cesario A, Granone P,
Nicholson AG, Goldstraw P, Ratcliffe C, Tetlow M, Leigh I, Harris AL, Gatter
KC, Pezzella F. Vascular phenotype in angiogenic and non-angiogenic lung non-small
cell carcinomas. Br J Cancer 2002; 86: 244-249.
Petersen
VC, Baxter KJ, Love SB, Shepherd NA. Identification of objective
pathological prognostic determinants and models of prognosis in Dukes’ B colon
cancer. Gut 2002; 51: 65-69.
Pocock
SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in
clinical trials: good practice and pitfalls. Lancet 2002; 359:
1686-1689.
Schulz
KF, Chalmers I, Altman DG. The landscape and lexicon of blinding in
randomized trials. Ann Intern
Med 2002; 136: 254-259.
Sterne
JAC, Jüni P, Schulz KF, Altman DG, Bartlett C, Egger M. Statistical
methods for assessing the influence of study characteristics on treatment
effects in ‘meta-epidemiological’ research. Stat Med 2002; 21:
1513-1524.
Straus
SE, McAlister FA, Sackett DL, Deeks JJ. Accuracy of history, wheezing,
and forced expiratory time in the diagnosis of chronic obstructive pulmonary
disease. J Gen Intern Med 2002; 17: 684-688.
Sullivan
PB, Juszczak E, Lambert BR, Rose M, Ford-Adams ME, Johnson A. Impact of
feeding problems on nutritional intake and growth: Oxford Feeding Study II. Dev
Med Child Neurol 2002; 44: 461-467.
Summers
KE, Davies AJ, Matthews J, Jenner MJ, Cornelius V, Amess JA, Norton AJ,
Rohatiner AZ, Fitzgibbon J, Lister TA, Goff LK. The relative role of peripheral
blood and bone marrow for monitoring molecular evidence of disease in
follicular lymphoma by quantitative real-time polymerase chain reaction. Br
J Haematol 2002; 118: 563-566.
Whitlock
G, Clark TG. The effect of missing values for covariates. Epidemiology
2002; 13: 113.
Willams
C, Collingwood M, Simera I, Grafton C. Short versus long duration
infusions of paclitaxel for any advanced adenocarcinoma. Cochrane Database of
Systematic Reviews: Reviews 2002 Issue 1. John Wiley & Sons, Ltd,
Cichester, UK DOI: 10 1002/146 2002.
Wyatt JC, Liu JLY. Basic concepts in medical informatics. J Epidemiol
Comm Health 2002; 56: 808-812.
